Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-22-034617

Director acquired 3,356 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
SCHIFF ANDREW N Director 2022-06-03 Option exercise +3,356 19,565 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
SCHIFF ANDREW N Director 2022-06-02 Grant or award · Stock Option (Right to Buy) +15,750 15,750 D: show line 2 in the form
SCHIFF ANDREW N Director 2022-06-02 Grant or award · Restricted Stock Units +4,507 4,507 D: show line 3 in the form
SCHIFF ANDREW N Director 2022-06-03 Option exercise · Restricted Stock Units −3,356 0 D: show line 4 in the form
Loading xslF345X03/doc4.xml…